01.11.2016 • NewsDede WillamsCrackerLG

LG to Expand Output of Daesan Cracker

South Korean petrochemical producer LG Chem said it plans to expand output of its cracker at Daesan by 230,000 t/y as of 2019. The upgrade, which will cost the equivalent of €227 million, will bring capacity at the site to 1.27 million t/y and the company’s total ethylene capability, including the 1.16 million t/y output of the Yeosu, Korea, cracker, to 2.43 million t/y.

LG Chem said the expansion upstream is intended to shift its production focus to higher value-added products and allow it to maintain its lead in its markets. The upgrade also reflects plans by the Korean government to restructure the country’s industry to reduce oversupply in an effort to counter pressure from competitors in China, the largest export market for Korean chemicals.

At the same time, the Korean player plans to convert one of its two polystyrene plants at Yeosu to produce ABS by the first half of 2017 and thus help reduce pressure from overcapacity in the polystyrene market.  The conversion is expected to increase ABS output by 30,000 t/y to 880,000 t/y while at the same time cutting PS production to 50,000 t/y from currently 100,000 t/y.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.